ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹221 Cr | ₹1232 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 3.64% | 3.27% |
6 Month | -6.54% | -5.79% |
1 Year | 15.59% | 14.65% |
3 Year | 23.7% | 24.71% |
5 Year | - | 22.05% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 5.42% | 5.28% |
1 Year | 3.19% | 3.14% |
3 Year | 22.52% | 23.44% |
5 Year | - | 19.45% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 20.48% | 9.47% |
3 Year | 18.71% | 18.04% |
5 Year | - | 14.89% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.61% | 16.16% |
Sharp | 0.93% | 0.95% |
Beta | 0.94% | 0.98% |
Alpha | -0.87% | -0.66% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 7.57 | 5.06 |
Mid Cap | 31.22 | 31.87 |
Small Cap | 32.03 | 27.82 |
Large Cap | 29.19 | 35.26 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 8.42 | 4.34 |
Healthcare | 88.76 | 93.44 |
Basic Materials | 2.08 | 2.22 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
Mahindra Manulife Small Cap Fund - Regular Plan - Growth
3Y Returns0%
Axis Small Cap Fund Regular Growth
3Y Returns24.68%
Bandhan ELSS Tax saver Fund - Regular Plan - Growth
3Y Returns20.53%
Mirae Asset ELSS Tax Saver Fund-Regular Plan-Growth
3Y Returns20.82%
Bajaj Finserv Overnight Fund Regular - Growth
3Y Returns0%
Sundaram Overnight Fund Regular Plan - Growth
3Y Returns6.33%
Nippon India Small Cap Fund - Growth Plan - Bonus Option
3Y Returns27.3%
Axis Small Cap Fund Regular Growth
3Y Returns24.68%